Skip to main content

RxHighlights

A monthly overview of treatment guidelines, important literature and key issues influencing today’s pharmacy and health care environment.

August 2025

Core topics in this month’s edition include:

  • Cyclobenzaprine Hydrochloride Tablets, 10 mg, 90 count - Drug Recall
  • Hernexeos® (zongertinib) – New drug approval
  • Saxenda® (liraglutide) – First-time generic

Download

Rx navigation